The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Sinovac...
July 13 2017 - 10:25AM
Business Wire
The Klein Law Firm announces the commencement of an
investigation of Sinovac Biotech Ltd (NASDAQ:SVA) concerning
possible violations of federal securities laws.
On December 21, 2016, an article published by SeekingAlpha.com
revealed that Sinovac's Chairman and Chief Executive Officer,
Weidong Yin, paid bribes to the Deputy Director General of the
Center for Drug Evaluation for the China Food and Drug
Administration and his wife, to help advance drug applications and
evaluations. Sinovac later announced on May 16, 2017 that the
Securities Exchange Commission is investigating the Company for
alleged bribery mentioned in SeekingAlpha's article, and that
Sinovac would not be able to file its annual financial results on
time.
If you suffered a loss in Sinovac and wish to obtain additional
information, please contact Joseph Klein, Esq. by telephone at
212-616-4899 or visit
http://www.kkclasslaw.com/SVA-Info-Request-Form-172.
Joseph Klein, Esq. is an experienced attorney and has also
practiced as a Certified Public Accountant. Mr. Klein represents
investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:Joseph Klein, Esq.Empire State Building350 Fifth
Avenue59th FloorNew York, NY 10118Telephone: (212) 616-4899Fax:
(347) 558-9665www.kleinstocklaw.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170713005669/en/
Klein Law FirmJoseph Klein, Esq.212-616-4899
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Apr 2023 to Apr 2024